401 related articles for article (PubMed ID: 28446236)
1. The malaria testing and treatment landscape in Benin.
; Zinsou C; Cherifath AB
Malar J; 2017 Apr; 16(1):174. PubMed ID: 28446236
[TBL] [Abstract][Full Text] [Related]
2. The malaria testing and treatment landscape in mainland Tanzania, 2016.
; Michael D; Mkunde SP
Malar J; 2017 Apr; 16(1):202. PubMed ID: 28521811
[TBL] [Abstract][Full Text] [Related]
3. The malaria testing and treatment market in Kinshasa, Democratic Republic of the Congo, 2013.
; Mpanya G; Tshefu A; Likwela JL
Malar J; 2017 Feb; 16(1):94. PubMed ID: 28241832
[TBL] [Abstract][Full Text] [Related]
4. Anti-malarial landscape in Myanmar: results from a nationally representative survey among community health workers and the private sector outlets in 2015/2016.
; Thein ST; Khin HSS; Thi A
Malar J; 2017 Apr; 16(1):129. PubMed ID: 28438197
[TBL] [Abstract][Full Text] [Related]
5. Private sector role, readiness and performance for malaria case management in Uganda, 2015.
; Kaula H; Buyungo P; Opigo J
Malar J; 2017 May; 16(1):219. PubMed ID: 28545583
[TBL] [Abstract][Full Text] [Related]
6. Got ACTs? Availability, price, market share and provider knowledge of anti-malarial medicines in public and private sector outlets in six malaria-endemic countries.
O'Connell KA; Gatakaa H; Poyer S; Njogu J; Evance I; Munroe E; Solomon T; Goodman C; Hanson K; Zinsou C; Akulayi L; Raharinjatovo J; Arogundade E; Buyungo P; Mpasela F; Adjibabi CB; Agbango JA; Ramarosandratana BF; Coker B; Rubahika D; Hamainza B; Chapman S; Shewchuk T; Chavasse D
Malar J; 2011 Oct; 10():326. PubMed ID: 22039838
[TBL] [Abstract][Full Text] [Related]
7. Evidence on anti-malarial and diagnostic markets in Cambodia to guide malaria elimination strategies and policies.
; Phok S; Lek D
Malar J; 2017 Apr; 16(1):171. PubMed ID: 28438204
[TBL] [Abstract][Full Text] [Related]
8. A cross-sectional study of the availability and price of anti-malarial medicines and malaria rapid diagnostic tests in private sector retail drug outlets in rural Western Kenya, 2013.
Kioko U; Riley C; Dellicour S; Were V; Ouma P; Gutman J; Kariuki S; Omar A; Desai M; Buff AM
Malar J; 2016 Jul; 15(1):359. PubMed ID: 27406179
[TBL] [Abstract][Full Text] [Related]
9. Evidence of successful malaria case management policy implementation in Cambodia: results from national ACTwatch outlet surveys.
; Novotny J; Singh A; Dysoley L; Sovannaroth S; Rekol H
Malar J; 2016 Apr; 15():194. PubMed ID: 27059952
[TBL] [Abstract][Full Text] [Related]
10. The malaria testing and treatment landscape in the southern Lao People's Democratic Republic (PDR).
; Phanalasy S
Malar J; 2017 Apr; 16(1):169. PubMed ID: 28438155
[TBL] [Abstract][Full Text] [Related]
11. Testing times: trends in availability, price, and market share of malaria diagnostics in the public and private healthcare sector across eight sub-Saharan African countries from 2009 to 2015.
; Hanson K; Goodman C
Malar J; 2017 May; 16(1):205. PubMed ID: 28526075
[TBL] [Abstract][Full Text] [Related]
12. The malaria testing and treatment landscape in Kenya: results from a nationally representative survey among the public and private sector in 2016.
; Musuva A; Ejersa W; Kiptui R; Memusi D; Abwao E
Malar J; 2017 Dec; 16(1):494. PubMed ID: 29268789
[TBL] [Abstract][Full Text] [Related]
13. Private sector opportunities and threats to achieving malaria elimination in the Greater Mekong Subregion: results from malaria outlet surveys in Cambodia, the Lao PDR, Myanmar, and Thailand.
; Phok S; Phanalasy S; Thein ST; Likhitsup A
Malar J; 2017 May; 16(1):180. PubMed ID: 28464945
[TBL] [Abstract][Full Text] [Related]
14. Case management of malaria fever in Cambodia: results from national anti-malarial outlet and household surveys.
Littrell M; Gatakaa H; Phok S; Allen H; Yeung S; Chuor CM; Dysoley L; Socheat D; Spiers A; White C; Shewchuk T; Chavasse D; O'Connell KA
Malar J; 2011 Oct; 10():328. PubMed ID: 22039922
[TBL] [Abstract][Full Text] [Related]
15. Oral artemisinin monotherapy removal from the private sector in Eastern Myanmar between 2012 and 2014.
Khin HS; Aung T; Thi A; White C;
Malar J; 2016 May; 15(1):286. PubMed ID: 27216408
[TBL] [Abstract][Full Text] [Related]
16. Availability and quality of anti-malarials among private sector outlets in Myanmar in 2012: results from a large, community-based, cross-sectional survey before a large-scale intervention.
Khin HS; Chen I; White C; Sudhinaraset M; McFarland W; Littrell M; Montagu D; Aung T
Malar J; 2015 Jul; 14():269. PubMed ID: 26169498
[TBL] [Abstract][Full Text] [Related]
17. The ACTwatch project: methods to describe anti-malarial markets in seven countries.
Shewchuk T; O'Connell KA; Goodman C; Hanson K; Chapman S; Chavasse D
Malar J; 2011 Oct; 10():325. PubMed ID: 22039780
[TBL] [Abstract][Full Text] [Related]
18. Subsidising artemisinin-based combination therapy in the private retail sector.
Opiyo N; Yamey G; Garner P
Cochrane Database Syst Rev; 2016 Mar; 3(3):CD009926. PubMed ID: 26954551
[TBL] [Abstract][Full Text] [Related]
19. Copayment mechanism in selected districts of Uganda: Availability, market share and price of quality assured artemisinin-based combination therapies in private drug outlets.
Ocan M; Nambatya W; Otike C; Nakalembe L; Nsobya S
PLoS One; 2024; 19(3):e0295198. PubMed ID: 38536824
[TBL] [Abstract][Full Text] [Related]
20. Availability and price of malaria rapid diagnostic tests in the public and private health sectors in 2011: results from 10 nationally representative cross-sectional retail surveys.
Poyer S; Shewchuk T; Tougher S; Ye Y; ; Mann AG; Willey BA; Thomson R; Amuasi JH; Ren R; Wamukoya M; Taylor M; Nguah SB; Mberu B; Kalolella A; Juma E; Festo C; Johanes B; Diap G; Bruxvoort K; Ansong D; Hanson K; Arnold F; Goodman C
Trop Med Int Health; 2015 Jun; 20(6):744-56. PubMed ID: 25728761
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
